Impact BioMedical Inc. (IBO)
AMEX: IBO
· Real-Time Price · USD
0.58
0.01 (2.29%)
At close: Aug 15, 2025, 3:59 PM
0.56
-2.75%
After-hours: Aug 15, 2025, 07:32 PM EDT
Impact BioMedical Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 428.33K | 41.27K | n/a | 131.2K | 369.12K | 433.16K | 137.32K | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 67.52K | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 428.33K | 41.27K | n/a | 131.2K | 369.12K | 433.16K | 69.8K | n/a | n/a |
Operating Income | -1.01M | -26.23M | -1.13M | -626K | -771K | -1.14M | -1.46K | -1.33K | 68.08K | -144.95K | -163.84K | -43.78K | 169.9K | 301.23K | -1.54M | -18.54K | 60.29K |
Interest Income | 3K | 3K | 3K | 3K | 3K | 3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.28M | -27.1M | 4.24M | -884K | -998K | -1.26M | -1.6K | -1.49K | -486.6K | -792.86K | -841.96K | -6.55M | -1.17M | -1.04M | -1.73M | -23.16K | -83.42K |
Net Income | -1.27M | -27.11M | 4.25M | -889K | -962K | -1.24M | -1.58K | -1.46K | -486.6K | -792.86K | -841.96K | -6.55M | -1.17M | -1.04M | -1.73M | -23.16K | -83.42K |
Selling & General & Admin | 509K | 591K | 719K | 335K | 305K | 274K | 590.83 | 606.73 | 414.75K | 591.59K | 555.91K | 826.06K | 1.11M | 1.07M | 1.56M | 20.77K | 11.49K |
Research & Development | 103K | -108K | 82K | n/a | 183K | 463K | 484.89K | 352.38K | n/a | n/a | 9.21K | 122.92K | 129.92K | 156.47K | n/a | n/a | n/a |
Other Expenses | 398K | 25.75M | 326K | 291K | 283K | 402K | -484.02K | -351.65K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.01M | 26.23M | 1.13M | 626K | 771K | 1.14M | 1.46K | 1.33K | 847.31K | 847.24K | 795.29K | 1.2M | 1.51M | 1.43M | 1.61M | 20.85K | 11.57K |
Interest Expense | 271K | 270K | 305K | 261K | 230K | 125K | n/a | n/a | 54.89K | 36.43K | 46.71K | 12.02K | 10.2K | 21.6K | 23.92K | n/a | n/a |
Selling & Marketing Expenses | 19K | 146K | 461K | 18K | 8K | 133K | 23.09 | 13.25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.01M | 26.23M | 1.13M | 626K | 771K | 1.14M | 1.46K | 1.33K | 847.31K | 847.24K | 795.29K | 1.2M | 1.51M | 1.43M | 1.67M | 20.85K | 11.57K |
Income Tax Expense | n/a | 33K | n/a | n/a | n/a | n/a | n/a | n/a | 54.89K | 36.43K | 46.71K | -115.52K | 10.2K | 21.6K | 23.92K | 2.31K | 71.86K |
Shares Outstanding (Basic) | 12.06M | 11.51M | 72M | 11.5M | 11.5M | 26.07M | 58.1K | 55.1K | 191.49M | 191.49M | 190.76M | 188.2M | 190.74M | 190.68M | 170.55M | 11M | 9.65M |
Shares Outstanding (Diluted) | 12.06M | 11.51M | 72M | 11.5M | 11.5M | 29.5M | 70.5K | 70.5K | 191.49M | 191.49M | 190.76M | 188.2M | 190.74M | 190.68M | 170.55M | 11M | 9.65M |
EPS (Basic) | -0.11 | -3.39K | 0.37 | -0.08 | -0.08 | -55.5 | -0.02 | -0.02 | -0.00 | -0.00 | -0.00 | -0.03 | -0.01 | -0.01 | -0.01 | -0.00 | -0.01 |
EPS (Diluted) | -0.11 | -3.39K | 0.06 | -0.08 | -0.08 | -62.8 | -0.03 | -0.03 | -0.00 | -0.00 | -0.00 | -0.03 | -0.01 | -0.01 | -0.01 | -0.00 | -0.01 |
EBITDA | -724K | -26.55M | 4.83M | -344K | -488K | -856K | -1.46K | -1.33K | -346.67K | -736.54K | -728.96K | -1.12M | -1.07M | -925.11K | -1.49M | -18.46K | 60.37K |
EBIT | -1.01M | -26.83M | 4.55M | -623K | -768K | -1.14M | -1.46K | -1.33K | n/a | n/a | n/a | n/a | n/a | n/a | -1.54M | -18.54K | 60.29K |
Depreciation & Amortization | 283K | 279K | 281K | 279K | 280K | 280K | n/a | n/a | 72.31K | 69.43K | 66.33K | 79.16K | 71.57K | 68.94K | 46.72K | 77.00 | 76.00 |